CNBC: Antitrust Regulators Won’t Challenge Aetna-CVS Deal

CNBC: Antitrust Regulators Won't Challenge Aetna-CVS Deal

Shares of CVS Health Corp. and health insurer Aetna Inc. rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger.


CNBC said Bloomberg reported the news, citing trade publication Reorg Research.


CVS Health Corp and Aetna announced the $69 billion deal on Dec. 3 last year, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies.


Aetna and CVS declined to comment.



Read on The Source

Share:

Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on The Latest News on Wall Street, Stocks, #Politics and Business news. Hedge Accordingly produces both original, and aggregated #Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About HEDGEaccordingly.com